Gland Pharma

quarterly
yearly
ParticularsJun '23Sep '23Dec '23Mar '24Jun '24
Revenue919.281,0521,1411,2221,061
Expenses665.29704.71769.50789.09760.20
EBITDA294.57388.22412.88479.78342.05
EBIT255.59347.97372.56437.22301.23
Profit Before Tax253.99347.07371.76432.69300.31
Net Profit187.58257.53276.81321.41222.92
Financial Ratios
Operating Profit Margin33.32%38.41%37.61%40.84%33.80%
Net Profit Margin21.22%25.48%25.21%27.36%22.03%
Earning Per Share (Diluted)11.3915.6316.8019.5113.53
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.3.6
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ